Galera Therapeutics (GRTX) Insider Trading & Ownership $0.02 +0.00 (+0.85%) As of 08/7/2025 03:15 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Galera Therapeutics (NASDAQ:GRTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.90%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$212.35KNumber OfInsiders Selling(Last 3 Years)0 Get GRTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Galera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GRTX Insider Buying and Selling by Quarter Galera Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/16/2023Mark BachledaInsiderBuy11,000$2.25$24,750.00 3/13/2023Chris DegnanCFOBuy10,000$1.96$19,600.00 3/10/2023Mel SorensenCEOBuy100,000$1.68$168,000.00 (Data available from 1/1/2013 forward) GRTX Insider Trading Activity - Frequently Asked Questions Who is on Galera Therapeutics' Insider Roster? The list of insiders at Galera Therapeutics includes Chris Degnan, Mark Bachleda, and Mel Sorensen. Learn more on insiders at GRTX. What percentage of Galera Therapeutics stock is owned by insiders? 12.90% of Galera Therapeutics stock is owned by insiders. Learn more on GRTX's insider holdings. Galera Therapeutics Key ExecutivesDr. J. Mel Sorensen M.D. (Age 67)CEO, President & Director Compensation: $632.64kDr. Robert A. Beardsley M.B.A. (Age 62)Ph.D., Co-Founder & COO Compensation: $464.59kMr. Christopher Degnan (Age 44)Chief Financial Officer Compensation: $474.05kMs. Jennifer Evans Stacey Esq. (Age 59)Chief Legal & Compliance Officer and Secretary Ms. Andie CollierChief Regulatory & Quality Affairs OfficerMs. Judy SchnyderSenior Vice President of Clinical Operations & Data Management More Insider Trading Tools from MarketBeat Related Companies BCLI Insider Buying MBIO Insider Buying CELZ Insider Buying SBFM Insider Buying CDIO Insider Buying INAB Insider Buying GTBP Insider Buying ADIL Insider Buying NKGN Insider Buying HCWB Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:GRTX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
